ID

20543

Descripción

A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00672386

Link

https://clinicaltrials.gov/show/NCT00672386

Palabras clave

  1. 2/3/17 2/3/17 -
Subido en

2 de marzo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT00672386

Eligibility Diabetes Mellitus, Type 2 NCT00672386

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
history of type 2 diabetes mellitus and treated with a stable dose of metformin for at least 2 months
Descripción

type 2 diabetes mellitus, metformin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0025598
women must be postmenopausal or surgically incapable of childbearing or if sexually active, be practicing an effective method of birth control
Descripción

Gender | Postmenopausal state | Childbearing Potential | Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0232970
UMLS CUI [3]
C3831118
UMLS CUI [4]
C0700589
bmi between 25 and 45 kg/m2
Descripción

bmi

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
hba1c between 7% and 10%, inclusive
Descripción

hba1c

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019018
fasting plasma glucose not exceeding 240mg/dl (13.3mmol/l)
Descripción

fasting plasma glucose

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0583513
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
diabetes other than type 2 diabetes mellitus
Descripción

diabetes type

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1320657
treatment with oral anti-diabetic agents (other than metformin) or insulin during the 12 weeks before baseline visit
Descripción

oral hypoglycemic, insulin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0359086
UMLS CUI [2]
C0021641
history of intolerance or hypersensitivity to sulfonylurea or sitagliptin
Descripción

intolerance or hypersensitivity to sulfonylurea or sitagliptin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0038766
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1565750
history of clinically significant gastrointestinal, hepatic or cardiovascular disease
Descripción

history of clinically significant gastrointestinal, hepatic or cardiovascular disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0009488
UMLS CUI [2]
C0017178
UMLS CUI [3]
C0023895
UMLS CUI [4]
C0007222
active proliferative diabetic retinopathy
Descripción

active proliferative diabetic retinopathy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0154830
UMLS CUI [1,2]
C0205177
history of diabetic gastroparesis
Descripción

diabetic gastroparesis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0267176
concurrent use of systemic corticosteroid
Descripción

steroid therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149783

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00672386

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
type 2 diabetes mellitus, metformin
Item
history of type 2 diabetes mellitus and treated with a stable dose of metformin for at least 2 months
boolean
C0011860 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
Gender | Postmenopausal state | Childbearing Potential | Contraceptive methods
Item
women must be postmenopausal or surgically incapable of childbearing or if sexually active, be practicing an effective method of birth control
boolean
C0079399 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C3831118 (UMLS CUI [3])
C0700589 (UMLS CUI [4])
bmi
Item
bmi between 25 and 45 kg/m2
boolean
C1305855 (UMLS CUI [1])
hba1c
Item
hba1c between 7% and 10%, inclusive
boolean
C0019018 (UMLS CUI [1])
fasting plasma glucose
Item
fasting plasma glucose not exceeding 240mg/dl (13.3mmol/l)
boolean
C0583513 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
diabetes type
Item
diabetes other than type 2 diabetes mellitus
boolean
C1320657 (UMLS CUI [1])
oral hypoglycemic, insulin
Item
treatment with oral anti-diabetic agents (other than metformin) or insulin during the 12 weeks before baseline visit
boolean
C0359086 (UMLS CUI [1])
C0021641 (UMLS CUI [2])
intolerance or hypersensitivity to sulfonylurea or sitagliptin
Item
history of intolerance or hypersensitivity to sulfonylurea or sitagliptin
boolean
C0020517 (UMLS CUI [1,1])
C0038766 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1565750 (UMLS CUI [2,2])
history of clinically significant gastrointestinal, hepatic or cardiovascular disease
Item
history of clinically significant gastrointestinal, hepatic or cardiovascular disease
boolean
C0262926 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
C0017178 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0007222 (UMLS CUI [4])
active proliferative diabetic retinopathy
Item
active proliferative diabetic retinopathy
boolean
C0154830 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
diabetic gastroparesis
Item
history of diabetic gastroparesis
boolean
C0267176 (UMLS CUI [1])
steroid therapy
Item
concurrent use of systemic corticosteroid
boolean
C0149783 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial